Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT06079203 · ClinicalTrials.gov registry record · NA

ED-LEAD: Emergency Departments Leading the Transformation of Alzheimer's and Dementia Care

A NA study of Alzheimer Disease and Alzheimer's Disease Related Dementia, sponsored by NYU Langone Health.

Active
Registry status
NA
Development phase
19,200
Enrollment target
1
Study location

NCT06079203 is a NA study of Alzheimer Disease and Alzheimer's Disease Related Dementia that is active but no longer recruiting, run by NYU Langone Health. The registered enrollment target is 19,200 participants, above the 2,688-participant average among 306 other Alzheimer Disease trials with a reported enrollment target (614% higher). The trial reports 1 study location across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT06079203, a NA study of Alzheimer Disease and Alzheimer's Disease Related Dementia, is active but no longer recruiting, sponsored by NYU Langone Health.

ACTIVE NOT RECRUITING
Registry status
NA
Development phase
19,200 participants
Enrollment target
1
Study location

Study Summary

The purpose of this study is to improve the care of persons living with dementia (PLWD) and their informal care partners by addressing emergency and post-emergency care through different combinations of three PLWD-care partner dyad focused interventions. The primary aims are to use coaching to help connect PLWD and their care partners with community support and services to improve transitional care, quality of care, care satisfaction and reduce future ED visits and hospitalizations.

Interventions

  • BEHAVIORAL Emergency Care Redesign (ECR)
  • BEHAVIORAL Nurse-led Telephonic Care (NLTC)
  • BEHAVIORAL Community Paramedic-led Transitions Intervention (CPTI)

Study Locations (1)

New York

  • NYU Langone Health - New York

Trial Details

FieldValue
Enrollment Target 19,200 participants
Start Date 2025-09-02
Est. Completion 2028-08-31
Phase NA

Sponsor

NYU Langone Health

1,164 total trials

What the Registry Record Tells You About NCT06079203

The ClinicalTrials.gov registry entry for NCT06079203 describes a study currently listed as active not recruiting, categorized as NA. The registered enrollment target is 19,200 participants, a figure that helps gauge the scale of data the investigators plan to collect, above the 2,688-participant average among 306 other Alzheimer Disease trials with a reported enrollment target (614% higher). The listed sponsor is NYU Langone Health, which has 1,164 total studies on file at ClinicalTrials.gov.

The record links to 2 conditions, with Alzheimer Disease appearing as the primary indexed condition, and to 3 interventions - of which Emergency Care Redesign (ECR) is the first listed.

NCT06079203 reports 1 study location spanning 1 distinct geographic area - top geographies include New York.

Frequently Asked Questions

What is clinical trial NCT06079203 about?

NCT06079203 is a clinical study titled "ED-LEAD: Emergency Departments Leading the Transformation of Alzheimer's and Dementia Care". The purpose of this study is to improve the care of persons living with dementia (PLWD) and their informal care partners by addressing emergency and post-emergency care through different combinations of three PLWD-care partner dyad focused interventions. The primary aims are to use coaching to help ...

What is the current status of trial NCT06079203?

This trial is currently active not recruiting. It is a NA study. The enrollment target is 19,200 participants. The study started on 2025-09-02. Estimated completion is 2028-08-31.

What conditions does trial NCT06079203 study?

This clinical trial studies the following conditions: Alzheimer Disease, Alzheimer's Disease Related Dementia.

What interventions are being tested in trial NCT06079203?

The interventions under investigation include: Emergency Care Redesign (ECR) (BEHAVIORAL), Nurse-led Telephonic Care (NLTC) (BEHAVIORAL), Community Paramedic-led Transitions Intervention (CPTI) (BEHAVIORAL).

Who is sponsoring clinical trial NCT06079203?

This trial is sponsored by NYU Langone Health, which has 1,164 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT06079203 being conducted?

This trial has 1 study location across New York. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Alzheimer Disease

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.